SCHEMBL6674202

SCHEMBL6674202

Cc1ccc(-c2ccc(CNC(=O)Oc3cc(NC(=O)c4ccccc4N4CCOCC4)cn3C)cc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.47
KDM4E B2RXH2 6/20 0.47
LMNA P02545 3/20 0.47
HSD17B10 Q99714 1/20 0.47
HIF1A Q16665 1/20 0.43
POLB P06746 3/20 0.42
L3MBTL1 Q9Y468 2/20 0.42
ITGA4 P13612 1/20 0.42
MITF O75030 1/20 0.42
HSP90AA1 P07900 1/20 0.42
G6PD P11413 1/20 0.42
PKM P14618 1/20 0.42
MC4R P32245 1/20 0.42
OPRK1 P41145 1/20 0.42
CCR6 P51684 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
GAA P10253 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7036532 0.87 POLB (0.54) ALDH1A1KDM4ELMNAHSD17B10HIF1A
SCHEMBL6675775 0.84 CHRNB2 (0.44) ALDH1A1KDM4ELMNAL3MBTL1MEN1
SCHEMBL7252308 0.81 ALDH1A1 (0.58) ALDH1A1KDM4ELMNAL3MBTL1MEN1
SCHEMBL6678715 0.81 RAB9A (0.49) ALDH1A1KDM4ELMNAHSD17B10POLB
SCHEMBL6673493 0.81 RAB9A (0.49) ALDH1A1KDM4ELMNAHSD17B10HIF1A
SCHEMBL6674613 0.81 MAPT (0.41) ALDH1A1KDM4ELMNAHSD17B10POLB
SCHEMBL6675696 0.80 LMNA (0.43) ALDH1A1LMNAL3MBTL1KMT2ATP53
SCHEMBL7252437 0.80 HPGD (0.46) ALDH1A1KDM4EHSD17B10L3MBTL1MEN1
SCHEMBL7041929 0.79 L3MBTL1 (0.50) ALDH1A1KDM4ELMNAHSD17B10POLB
SCHEMBL6680330 0.78 MTTP (0.49) KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1465613-A2 COMBINATION OF MTP INHIBITORS OR APOB SECRETION INHIBITORS WITH FIBRATES FOR USE AS DRUGS Boehringer Ingelheim Pharma GmbH & Co. KG (DE) 2004-10-13 EP disclosed
WO-2003057205-A2 COMBINATION OF MTP INHIBITORS OR APOB SECRETION INHIBITORS WITH FIBRATES FOR USE AS DRUGS BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2003-07-17 WO disclosed
WO-2003004020-A1 HETEROARYL CARBOXYLIC ACID AMIDES, THE PRODUCTION THEREOF AND THE USE OF THE SAME AS INHIBITORS OF THE MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN (MTP) BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2003-01-16 WO disclosed